Herman Waldmann
- Immunology top 0.01%
- T-cell and B-cell Immunology 241
- Immune Cell Function and Interaction 171
- Immunotherapy and Immune Responses 120
- Transplantation top 0.05%
- Renal Transplantation Outcomes and Treatments 41
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation 80
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Monoclonal and Polyclonal Antibodies Research 120
- Genetics top 0.1%
- Diabetes and associated disorders 33
-
- Glycosylation and Glycoproteins Research 46
- Co-authors
- Stephen CobboldG HaleMike ClarkLuís GraçaElizabeth AdamsPaul J. FairchildLutz RiechmannShixin Qin
- Cited by
- ImmunologyTransplantationHematology
- Journals
- European Journal of Immunology (36 papers)The Journal of Immunology (34 papers)Transplantation (29 papers)
- Partner nations
- United KingdomUnited StatesSouth Sudan
In The Last Decade
Herman Waldmann
531 papers receiving 34.8k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Immunology 22.3k
- Transplantation 2.5k
- Hematology 5.8k
- Radiology, Nuclear Medicine and Imaging 6.3k
- Genetics 2.9k
Countries citing papers authored by Herman Waldmann
This map shows the geographic impact of Herman Waldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Waldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Waldmann more than expected).
Fields of papers citing papers by Herman Waldmann
This network shows the impact of papers produced by Herman Waldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Waldmann. The network helps show where Herman Waldmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Herman Waldmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 0 | |
| 2 | 2018 | 47 | |
| 3 | 2011 | 161 | |
| 4 | Plenary Session 3: Found in Translation: Learning Immunology from Human Therapeutic Trials | 2011 | 1 |
| 5 | 2009 | 264 | |
| 6 | Reprogramming the immune system. | 2008 | 3 |
| 7 | Early infiltration of allografts by a subset of host mononuclear cells bearing inhibitory Ly49 receptors determines development of allograft rejection or tolerance. | 2005 | 1 |
| 8 | Neutralising TNF activity leads to remission in refractory posterior non-infectious uveitis | 2004 | 1 |
| 9 | Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. | 2003 | 5 |
| 10 | Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. | 2001 | 4 |
| 11 | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). | 2001 | 4 |
| 12 | 1999 | 6 | |
| 13 | Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia. | 1996 | 2 |
| 14 | 1994 | 68 | |
| 15 | ANCA POSITIVE AND ANCA NEGATIVE MICROSCOPIC POLYARTERITIS | 1994 | 4 |
| 16 | AN IN-VIVO MODEL FOR DETERMINING RULES OF ANTIBODY DESIGN | 1994 | 1 |
| 17 | ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES | 1993 | 3 |
| 18 | Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion. | 1993 | 8 |
| 19 | 1989 | 3 | |
| 20 | Antigen-non-specific T-cell factor in B-cell activation. Origin, biological properties and failure to show a relationship to H-2. | 1976 | 25 |
About Herman Waldmann
Herman Waldmann is a scholar working on Immunology, Transplantation, Hematology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 539 papers that have together received 36.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (241 papers), Immune Cell Function and Interaction (171 papers), Immunotherapy and Immune Responses (120 papers), Monoclonal and Polyclonal Antibodies Research (120 papers), Hematopoietic Stem Cell Transplantation (80 papers), Glycosylation and Glycoproteins Research (46 papers), Renal Transplantation Outcomes and Treatments (41 papers) and Diabetes and associated disorders (33 papers). The work is most often cited by research in Immunology (22.3k citations), Transplantation (2.5k citations), Hematology (5.8k citations), Radiology, Nuclear Medicine and Imaging (6.3k citations) and Genetics (2.9k citations). Herman Waldmann has collaborated with scholars based in United Kingdom, United States and South Sudan. Frequent co-authors include Stephen Cobbold, G Hale, Mike Clark, Luís Graça, Elizabeth Adams, Paul J. Fairchild, Lutz Riechmann, Shixin Qin, Masahide Tone and Greg Winter. Their work appears in journals such as European Journal of Immunology, The Journal of Immunology, Transplantation, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.